AMGN
Amgen Inc.
November 4, 2026 · pre-market
- Rarity
- 1.82
- Peak move
- +6.92%
- Float cap
- $247.6B
Still running — rarity and peak move can only rise from here.
Amgen is a biotechnology company that discovers, develops, manufactures, and delivers innovative medicines for serious diseases. It focuses on areas of high unmet medical need and operates in one segment: human therapeutics. The company sells these medicines to patients in approximately 100 countries, with sales and marketing concentrated in the United States and Europe.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNot searched yet.A blank here does not mean there was no cause.